Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Calvin AD et al. – While estimates of benefit among patients with diabetes remain imprecise, the analysis suggests that the relative benefit of aspirin is similar in patients with and without diabetes.

Related Articles

Efficacy of aspirin for secondary prevention in patients with peripheral artery disease
Expert Review of Cardiovascular Therapy, 10/16/09    Relevance Score: 93%

Efficacy of different doses of aspirin in decreasing blood levels of inflammatory markers in patients with cardiovascular metabolic syndrome
Journal of Pharmacy and Pharmacology, 11/04/09    Relevance Score: 91%

Antithrombotic medication for stroke prevention
Expert Review of Cardiovascular Therapy, 10/20/09    Relevance Score: 91%

Comparison of Bleeding Complications With Omega-3 Fatty Acids + Aspirin + Clopidogrel—Versus—Aspirin + Clopidogrel in Patients With Cardiovascular Disease
The American Journal of Cardiology, 10/13/09    Relevance Score: 91%

Time-Dependent Effects of Low-Dose Aspirin on Plasma Renin Activity, Aldosterone, Cortisol, and Catecholamines
Hypertension, 10/12/09    Relevance Score: 89%

Today in Clinical Pharmacology...keeping you current

Anti-platelet Agents
Discovery Medicine, 12/15/09

Use of oral bisphosphonates and risk of venous thromboembolism: A population-based case-control study
Osteoporosis International, 12/15/09

Long-term levetiracetam treatment in patients with epilepsy: 3-year follow up
Acta Neurologica Scandinavica, 12/15/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address